Loading clinical trials...
Loading clinical trials...
A Phase IV Longitudinal Study of SUBLOCADE (SUBUTEX Prolonged Release) Clinical Outcomes in Adults With Opioid Use Disorder (Opioid Dependence)
This study will provide the opportunity to generate data on the long-term use of SUBLOCADE under real-world conditions, and to observe enduring changes in lifestyle, health, and sociodemographic factors that are part of the recovery process. Long-term patterns of abstinence/opioid misuse as well as measures of participants' physical, psychological, social, and economic well-being will be monitored to better understand factors associated with recovery from opioid use disorder (OUD). Therefore, this study will observe participants up to a maximum of 4 years.
This is a Phase IV, prospective, multicentre, multinational, open-label, real-world observational study in participants with current or a history of OUD/opioid dependence.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
ATP Clinical Research
Costa Mesa, California, United States
Neighborhood Healthcare-Institute of Health
Escondido, California, United States
Elevate Health and Wellness
Westport, Connecticut, United States
United Research Institute
Hialeah, Florida, United States
Zenith Clinical Research LLC
Hollywood, Florida, United States
Jackson Health Community Center
Miami, Florida, United States
G+C Research Group
Miami, Florida, United States
Atlanta VA Medical Center
Decatur, Georgia, United States
University of Kansas Medical Center
Kansas City, Kansas, United States
Collective Medical Research.
Prairie Village, Kansas, United States
Start Date
August 31, 2023
Primary Completion Date
August 31, 2025
Completion Date
August 31, 2025
Last Updated
October 16, 2025
480
ACTUAL participants
Lead Sponsor
Indivior Inc.
NCT06651177
NCT06843213
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions